inline storage pouches and systems for receiving and retaining body fluids from an animal are presented. The inline storage pouch include a flexible pouch body has an interior portion with a fluid storage material disposed within the interior portion. In addition to receiving body fluids, the inline storage pouch may fluidly couple a pressure sensing conduit between a first port and a second port using a first bypass conduit. The first port may be a patient-port interface. The second port may be a device-port interface. Multiple sensors and bypass conduits may be included and associated with a microprocessor that is configured to locate blockages or determine when the inline storage pouch is full. Another inline storage pouch has two chambers and receives and discharges fluids from a pouch connector. Other pouches, systems, and methods are presented herein.

Patent
   10532194
Priority
Aug 31 2011
Filed
Jul 26 2016
Issued
Jan 14 2020
Expiry
Oct 26 2033
Extension
565 days
Assg.orig
Entity
Large
16
155
EXPIRED<2yrs
1. An inline storage pouch for use with body fluids, the inline storage pouch comprising:
a flexible pouch body comprising a first wall, a second wall, and a partitioning wall whereby an interior portion is formed having a first chamber and a second chamber, wherein the flexible pouch body has a proximal end and a distal end;
a first manifolding material disposed within the first chamber;
a fluid storage material disposed within the second chamber;
a first wicking member and a second wicking member surrounding the fluid storage material;
a pouch connector coupled to the flexible pouch body at the proximal end, wherein the pouch connector fluidly couples body fluids received to the second chamber and fluidly couples reduced pressure received from a reduced-pressure source to the first chamber; and
wherein the partitioning wall of the flexible pouch body has a proximal end and a distal end, and wherein the proximal end of the partitioning wall has an exudate aperture for receiving a portion of the pouch connector and wherein the distal end of the partitioning wall has a return aperture for allowing fluid flow from the second chamber to the first chamber.
10. A method of processing liquids, the method comprising:
providing an inline storage pouch, wherein the inline storage pouch comprises:
a flexible pouch body comprising a first wall, a second wall, and a partitioning wall whereby an interior portion is formed having a first chamber and a second chamber, wherein the flexible pouch body has a proximal end and a distal end,
a first manifolding material disposed within the first chamber,
a fluid storage material disposed within the second chamber,
a first wicking member and a second wicking member surrounding the fluid storage material,
a pouch connector coupled to the flexible pouch body at the proximal end, wherein the pouch connector fluidly couples body fluids received to the second chamber and fluidly couples reduced pressure received from a reduced-pressure source to the first chamber, and
wherein the partitioning wall of the flexible pouch body has a proximal end and a distal end, and wherein the proximal end of the partitioning wall has an exudate aperture for receiving a portion of the pouch connector and wherein the distal end of the partitioning wall has a return aperture for allowing fluid flow from the second chamber to the first chamber;
delivering reduced pressure to the pouch connector;
delivering the liquids to the pouch connector;
retaining the liquids in the fluid storage material in the second chamber; and
flowing reduced pressure from the first chamber to the second chamber.
2. The inline storage pouch of claim 1, wherein the pouch connector comprises:
a connector body formed with an exudate chamber having an intake port for receiving the body fluids and an outlet for discharging the body fluids;
the connector body is also formed with a reduced-pressure chamber having an intake port for receiving fluids and an outlet port for discharging fluids, the outlet port of the reduced-pressure chamber is for receiving the reduced pressure from the reduced-pressure source;
wherein the exudate chamber and reduced-pressure chamber are fluidly isolated from each other within the pouch connector;
a displacement conduit fluidly coupled to the outlet port and the second chamber for delivering the body fluids from the exudate chamber to the second chamber; and
wherein the intake port of the reduced-pressure chamber is fluidly coupled to the first chamber for delivering reduced pressure to the first chamber.
3. The inline storage pouch of claim 2, wherein the pouch connector further comprises a plurality of offsets on the connector body proximate to the intake port of the reduced-pressure chamber.
4. The inline storage pouch of claim 2, wherein the intake port of the exudate chamber is substantially parallel to the outlet port of the reduced-pressure chamber.
5. The inline storage pouch of claim 4, wherein the flexible pouch body has a longitudinal axis that is substantially parallel to the axis of the intake port of the exudate chamber.
6. The inline storage pouch of claim 2, wherein the intake port of the exudate chamber comprises a tube connector and the outlet port of the reduced-pressure chamber comprises a tube connector.
7. The inline storage pouch of claim 1, further comprising a first hydrophobic filter covering the return aperture formed on the partitioning wall.
8. The inline storage pouch of claim 1, further comprising a second manifolding material disposed in the second chamber.
9. The inline storage pouch of claim 1,
wherein the pouch connector comprises:
connector body formed with an exudate chamber having an intake port for receiving the body fluids and an outlet for discharging the body fluids,
the connector body also formed with a reduced-pressure chamber having an intake port for receiving fluids and an outlet port for discharging fluids, the outlet port of the reduced-pressure chamber is for receiving the reduced pressure from the reduced-pressure source,
wherein the exudate chamber and reduced-pressure chamber are fluidly isolated from each other within the connector body, and
a displacement conduit fluidly coupled to the outlet port and the second chamber for delivering the fluids from the exudate chamber to the second chamber,
wherein the intake port of the reduced-pressure chamber is fluidly coupled to the first chamber for delivering reduced pressure to the first chamber,
a plurality of offsets on the connector body proximate to the intake port of the reduced-pressure chamber,
wherein the intake port of the exudate chamber is substantially parallel to the outlet port of the reduced-pressure chamber, and
wherein the flexible pouch body has a longitudinal axis that is substantially perpendicular to the axis of the outlet of the exudate chamber;
a first hydrophobic filter covering the return aperture formed on the partitioning wall;
and
a second manifolding material, wherein the second manifolding material is disposed within the second chamber.
11. The method of processing liquids from an animal of claim 10,
wherein the pouch connector comprises:
a connector body formed with an exudate chamber having an intake port for receiving the body fluids and an outlet for discharging the body fluids;
the connector body also formed with a reduced-pressure chamber having an intake port for receiving fluids and an outlet port for discharging fluids, the outlet port of the reduced-pressure chamber is for receiving the reduced pressure from the reduced-pressure source;
wherein the exudate chamber and reduced-pressure chamber are fluidly isolated from each other within the connector body;
a displacement conduit fluidly coupled to the outlet port and the second chamber for delivering the fluids from the exudate chamber to the second chamber; and
wherein the intake port of the reduced-pressure chamber is fluidly coupled to the first chamber for delivering reduced pressure to the first chamber.

The present application is a divisional of U.S. patent application Ser. No. 13/442,519, entitled “INLINE STORAGE POUCHES FOR USE WITH BODY FLUIDS,” filed on 9 Apr. 2012, which claims the benefit, under 35 USC § 119(e), of the filings of U.S. Provisional Patent Application Ser. No. 61/543,558, entitled “INLINE STORAGE POUCHES FOR USE WITH BODY FLUIDS,” filed on 5 Oct. 2011, which is incorporated herein by reference for all purposes; and U.S. Provisional Patent Application Ser. No. 61/529,709, entitled “EVAPORATIVE FLUID POUCH AND SYSTEMS FOR USE WITH BODY FLUIDS,” filed 31 Aug. 2011, which is incorporated herein by reference for all purposes.

The present disclosure relates generally to medical treatment systems for treating tissue sites that produce liquids, such as exudate, and for processing body fluids. More particularly, but not by way of limitation, the present disclosure relates to inline storage pouches, systems, and methods for receiving and storing liquids from an animal.

Caring for wounds is important in the healing process. Wounds often produce considerable liquids, e.g., exudate. Medical dressings are often used in wound care to address the production of liquids from the wound. If not properly addressed, liquids at the wound can lead to infection or maceration at or near the wound. As used throughout this document, “or” does not require mutual exclusivity. Wound dressings may be used alone or as an aspect of applying reduced pressure to a tissue site.

Clinical studies and practice have shown that providing reduced pressure in proximity to a tissue site augments and accelerates the growth of new tissue at the tissue site. The applications of this phenomenon are numerous, but application of reduced pressure has been particularly successful in treating wounds. This treatment (frequently referred to in the medical community as “negative pressure wound therapy,” “reduced pressure therapy,” or “vacuum therapy”) provides a number of benefits, which may include faster healing and increased formulation of granulation tissue.

According to an illustrative embodiment, an inline storage pouch for use with body fluids from an animal includes a flexible pouch body having an interior portion, a fluid storage material disposed within the interior portion, and a first port. As used herein, it should be understood that the term “animal” includes humans. The first port is formed on the flexible pouch body and is configured to connect to a first multi-lumen conduit extending from the flexible pouch body to the animal. The first multi-lumen conduit has at least one sensing lumen and at least one reduced pressure lumen. The inline storage pouch also includes a second port formed on the flexible pouch body. The second port is configured to fluidly connect to a second multi-lumen conduit extending from the flexible pouch body to a reduced pressure source. The second multi-lumen conduit has at least one sensing lumen and at least one reduced pressure lumen.

The inline storage pouch also includes a first bypass conduit disposed within and fluidly isolated from the interior portion of the flexible pouch body. The first bypass conduit has a first end and a second end. The first end of the first bypass conduit is fluidly coupled to the at least one sensing lumen of the first multi-lumen conduit. The second end of the first bypass conduit is fluidly coupled to the at least one sensing lumen of the second multi-lumen conduit. The first port may be a patient-port interface. The second port may be a device-port interface.

According to another illustrative embodiment, a system for treating a tissue site on an animal with reduced pressure includes a wound dressing for disposing proximate to the tissue site for providing reduced pressure to the tissue site. The wound dressing has a reduced-pressure interface. The reduced-pressure interface includes a reduced-pressure-supply conduit and a pressure-assessment conduit. The system further includes an inline storage pouch, a first multi-lumen conduit, and a second multi-lumen conduit. The first multi-lumen conduit has at least one sensing lumen and at least one reduced pressure lumen. The at least one sensing lumen of the first multi-lumen conduit is fluidly coupled to the pressure-assessment conduit of the reduced-pressure interface. The at least one reduced-pressure lumen of the first multi-lumen conduit is fluidly coupled to the reduced-pressure-supply conduit.

The inline storage pouch includes a flexible pouch body having an interior portion, a fluid storage material disposed within the interior portion, a first port formed on the flexible pouch body configured to connect to the first multi-lumen conduit, and a second port formed on the flexible pouch body. The second port is configured to fluidly couple to a second multi-lumen conduit that extends from the flexible pouch body to a reduced pressure source. The second multi-lumen conduit has at least one sensing lumen and at least one reduced pressure lumen. The inline storage pouch also includes a first bypass conduit disposed within and fluidly isolated from the interior portion of the flexible pouch body. The bypass conduit has a first end and a second end. The first end of the bypass conduit is fluidly coupled to the at least one sensing lumen of the first multi-lumen conduit. The second end of the bypass conduit is fluidly coupled to the at least one sensing lumen of the second multi-lumen conduit.

The system also includes a reduced-pressure source and a first pressure-sensing unit. The at least one reduced pressure lumen of the second multi-lumen conduit is fluidly coupled to the reduced-pressure source. The at least one sensing lumen of the second multi-lumen conduit is fluidly coupled to the first-pressure sensing device.

According to another illustrative embodiment, a method of storing liquids from an animal includes providing an inline storage pouch. The inline storage pouch includes a flexible pouch body having an interior portion, a fluid storage material disposed within the interior portion, and a first port. The first port is formed on the flexible pouch body. The first port is configured to connect to a first multi-lumen conduit that extends from the flexible pouch body to the animal. The first multi-lumen conduit has at least one sensing lumen and at least one reduced pressure lumen.

The inline storage pouch also includes a second port formed on the flexible pouch body. The second port is configured to fluidly connect to a second multi-lumen conduit that extends from the flexible pouch body to a reduced pressure source. The second multi-lumen conduit has at least one sensing lumen and at least one reduced pressure lumen. The inline storage pouch also includes a first bypass conduit disposed within and fluidly isolated from the interior portion of the flexible pouch body. The first bypass conduit has a first end and a second end. The first end of the first bypass conduit is fluidly coupled to the at least one sensing lumen of the first multi-lumen conduit. The second end of the first bypass conduit is fluidly coupled to the at least one sensing lumen of the second multi-lumen conduit.

The method also includes coupling the at least one reduced pressure lumen of the first multi-lumen conduit to the animal to receive the liquids from the animal and coupling the at least one sensing lumen of the first multi-lumen conduit to the animal to receive the pressure from the animal proximate to where the liquids are removed. The method also includes providing reduced pressure to the at least one reduced pressure lumen of the second multi-lumen conduit and coupling a pressure-sensing unit to the at least one sensing lumen of the second multi-lumen conduit.

According to another illustrative embodiment, an inline storage pouch for use with body fluids from an animal includes a flexible pouch body having a first wall, a second wall, and a partitioning wall whereby an interior portion is formed. The interior portion has a first chamber and a second chamber. The flexible pouch body has a proximal end and a distal end. The inline storage pouch also includes a first manifolding material disposed within the first chamber and a fluid storage material disposed within the second chamber. The inline storage pouch further includes a pouch connector coupled to the flexible pouch body at the proximal end. The pouch connector fluidly couples fluids received from the animal to the second chamber and fluidly couples reduced pressure received from a reduced-pressure source to the first chamber. The partitioning wall of the flexible pouch body has a proximal end and a distal end, and the proximal end of the partitioning wall has an exudate aperture for receiving a portion of the pouch connector. The distal end of the partitioning wall has a return aperture for allowing fluid flow from the second chamber to the first chamber.

According to another illustrative embodiment, a pouch connector for use with an inline storage pouch includes a connector body formed with an exudate chamber having an intake port for receiving the fluids from the animal and an outlet for discharging the fluids. The connector body is also formed with a reduced-pressure chamber having an intake port for receiving fluids and an outlet port for discharging fluids. The outlet port of the reduced-pressure chamber is for receiving the reduced pressure from the reduced-pressure source. The exudate chamber and reduced-pressure chamber are fluidly isolated from each other within the pouch connector. The pouch connector also includes a displacement conduit fluidly coupled to the outlet port of the exudate chamber for delivering the fluids from the exudate chamber to a portion of the inline storage pouch. The intake port of the reduced-pressure chamber is fluidly coupled to another portion of the inline storage pouch for delivering reduced pressure thereto.

According to another illustrative embodiment, a method of manufacturing an inline storage pouch for use with body fluids from an animal includes forming a flexible pouch body having a first wall, a second wall, and a partitioning wall whereby an interior portion is formed having a first chamber and a second chamber. The flexible pouch body has a proximal end and a distal end. The method further includes disposing a first manifolding material within the first chamber, disposing a fluid storage material within the second chamber, and coupling a pouch connector to the flexible pouch body at the proximal end. The pouch connector fluidly couples fluids from the animal to the second chamber and fluidly couples reduced pressure received from a reduced-pressure source to the first chamber. The partitioning wall of the flexible pouch body has a proximal end and a distal end. The method further includes forming an exudate aperture proximate the proximal end of the partitioning wall, disposing a portion of the pouch connector through the exudate aperture, and forming a return aperture proximate the distal end of the partitioning wall for allowing fluid flow from the second chamber into the first chamber.

Other aspects, features, and advantages of the illustrative embodiments will become apparent with reference to the drawings and detailed description that follow.

FIG. 1 is a schematic, perspective view of an illustrative system for treating a tissue site on an animal with reduced pressure that involves storing liquids in an inline storage pouch;

FIG. 2 is a schematic diagram, with a portion shown in cross section and a portion in plan view, of an illustrative system for treating a tissue site on an animal with reduced pressure that involves storing liquids in an inline storage pouch;

FIG. 3 is a schematic, elevation view of an illustrative patient-port interface;

FIG. 4 is a schematic, perspective view showing a pouch-facing side of the patient-port interface of FIG. 3;

FIG. 5 is a schematic, perspective view showing a first side (opposite the pouch-facing side) of an illustrative embodiment of a device-port interface;

FIG. 6 is a schematic, plan view of a second, pouch-facing side of the illustrative embodiment of the device-port interface of FIG. 5;

FIG. 7 is a schematic cross section of an illustrative embodiment of the inline storage pouch shown in FIG. 2 taken along line A-A;

FIG. 8 is a schematic cross section of an illustrative embodiment of the inline storage pouch shown in FIG. 2 taken parallel to line A-A and through an optional fluid-communication button;

FIG. 9 is a schematic cross section of another illustrative embodiment of the inline storage pouch shown in FIG. 2 taken along line A-A;

FIG. 10 is a schematic cross section of another illustrative embodiment of the inline storage pouch shown in FIG. 2 taken along line A-A;

FIG. 11 is a schematic cross section of another illustrative embodiment of the inline storage pouch shown in FIG. 2 taken along line A-A;

FIG. 12 is a schematic cross section of another illustrative embodiment of the inline storage pouch shown in FIG. 2 taken along line A-A;

FIG. 13 is a schematic cross section of another illustrative embodiment of the inline storage pouch shown in FIG. 2 taken along line A-A;

FIG. 14 is a schematic cross section of another illustrative embodiment of the inline storage pouch shown in FIG. 2 taken along line A-A and shown on an animal;

FIG. 15 is a schematic plan view of an illustrative embodiment of an inline storage pouch;

FIG. 16 is a schematic, perspective view of, inter alia, a reduced-pressure indicator;

FIG. 17A is a schematic elevation view of the reduced-pressure indicator of FIG. 12 shown in an extended position;

FIG. 17B is a schematic elevation view of a portion of the reduced-pressure indicator of FIG. 12 shown in a retracted position;

FIG. 18 is a schematic plan view of an illustrative embodiment of an inline storage pouch;

FIG. 19 is a schematic plan view of an illustrative embodiment of an inline storage pouch;

FIG. 20 is a schematic plan view of an illustrative embodiment of an inline storage pouch;

FIG. 21 is a schematic, illustrative flow diagram of steps that may be performed using a microprocessor in an illustrative system for treating a tissue site on an animal with reduced pressure that involves storing liquids in an inline storage pouch;

FIG. 22 is a schematic, perspective view of an illustrative inline storage pouch for use with a system such as that shown in FIG. 1;

FIG. 23 is a schematic cross-sectional view of the inline storage pouch of FIG. 22;

FIG. 24 is a schematic, exploded perspective view of the inline storage pouch of FIGS. 22-23;

FIG. 25 is a schematic elevation view of an illustrative embodiment of a pouch connector shown in FIGS. 21-24;

FIG. 26 is a schematic cross-sectional view of the pouch connector of FIG. 25; and

FIG. 27 is a schematic, perspective view showing primarily a second, tissue-facing side of the pouch connector of FIGS. 25-26.

In the following detailed description of the illustrative, non-limiting embodiments, reference is made to the accompanying drawings that form a part hereof. These embodiments are described in sufficient detail to enable those skilled in the art to practice the invention, and it is understood that other embodiments may be utilized and that logical structural, mechanical, electrical, and chemical changes may be made without departing from the spirit or scope of the invention. To avoid detail not necessary to enable those skilled in the art to practice the embodiments described herein, the description may omit certain information known to those skilled in the art. The following detailed description is not to be taken in a limiting sense, and the scope of the illustrative embodiments is defined only by the appended claims.

Referring now to the drawings and initially to FIGS. 1-7, an illustrative embodiment of a system 100 for treating a tissue site 102 on an animal 104, which is deemed to include a human as shown, with reduced pressure is presented. The system 100 includes an inline storage pouch 106. The system 100 is shown on a human, but the system 100 may be used on any animal 104, e.g., horse, cow, dog, pig, turtle, etc. The system 100 includes a wound dressing 108 (or other fluid reception device), the inline storage pouch 106, and a therapy unit 110, which includes a reduced-pressure source 112. Liquids are delivered to the inline storage pouch 106 for storing. The liquids are removed from the animal 104 using reduced pressure. The liquids are from a tissue site 102, e.g., a wound site, but could also be from an ostomy bag or another source.

The system 100 may allow the user to position the weight of the inline storage pouch 106 and the therapy unit 110 at different locations on the animal. In other words, the weight of the components of the system 100 may be distributed at different locations as suggested in FIG. 1. Thus, the inline storage pouch 106 may be strapped to a portion of the animal 104, such as a leg, using straps 107 (or other attachment devices). At the same time, the therapy unit 110 may be attached at another location on the animal 104, e.g., a torso, using straps 111.

The inline storage pouch 106 is flexible. The flexibility allows the inline storage pouch 106 to conform to a portion of the animal's body thereby enhancing safety and comfort. In addition, the flexible nature of the inline storage pouch 106 allows the inline storage pouch 106 to be stored in a small space. The inline storage pouch 106 is relatively easy to manufacture compared to rigid canisters that have been used to collect liquids. Moreover, when the inline storage pouch 106 is used with non-human animals, the flexible nature may help prevent injury when the animal bumps surfaces or rolls over.

As shown best in FIG. 2, a wound 103 at tissue site 102 is through epidermis 114 and into dermis 116. The wound dressing 108 is disposed on the tissue site 102, e.g., the wound 103, and is operable to receive fluids from the tissue site 102. The wound dressing 108 may be any type of dressing for receiving fluids from the patient, but is shown as a dressing with a wound-interface manifold 118 and a drape 120. The wound dressing 108 may be any device that collects liquids whether a wound is involved or not. For example, in one illustrative embodiment, the wound dressing 108 may be a device for removing liquids from an ostomy bag. Typically, however, the wound dressing 108 is for removing liquids from a wound 103. Fluids, including liquids, from the tissue site 102 are delivered through a reduced-pressure interface 122 to a first multi-lumen conduit 124. The first multi-lumen conduit 124 is fluidly coupled to the inline storage pouch 106.

The reduced-pressure interface 122 includes a reduced-pressure-supply conduit 126 and a pressure-assessment conduit 128. The reduced-pressure-supply conduit 126 is fluidly coupled to a reduced-pressure lumen 130 in the first multi-lumen conduit 124. The pressure-assessment conduit 128 is fluidly coupled to a sensing lumen 132 in the first multi-lumen conduit 124. In one illustrative embodiment, the reduced-pressure interface 122 is a T.R.A.C.® Pad or Sensa T.R.A.C.® Pad available from KCI of San Antonio, Tex. The reduced-pressure interface 122 may be any device capable of accomplishing at least two functions: (1) fluidly coupling the reduced-pressure lumen 130 to the wound dressing 108 to deliver reduced pressure to the desired area and (2) fluidly coupling the sensing lumen 132 to a sealed space created by the drape 120.

The first multi-lumen conduit 124 is coupled to the inline storage pouch 106 at a first port 133. The first port 133 is formed on (including coupled to) the flexible pouch body 138. The flexible pouch body 138 has a first side 139 and a second, animal-facing side 141. The first port 133 may be formed on either side 139, 141, but is shown on the second, animal-facing side 141.

The first port 133 may be any device that accomplishes at least a couple functions. First, the first port 133 fluidly couples the reduced-pressure lumen 130 of the first multi-lumen conduit 124 to an interior portion 136 (see FIG. 7) of a flexible pouch body 138. Second, the first port 133 fluidly couples the sensing lumen 132 of the first multi-lumen conduit 124 to a first bypass conduit 140. The first bypass conduit 140 is formed in the interior portion 136 of the flexible pouch body 138 and yet is fluidly isolated from the interior portion 136. For example, without, limitation, the first port 133 may be a patient-port interface 134.

Referring now primarily to FIGS. 3-4, an illustrative embodiment of the patient-port interface 134 is presented. The patient-port interface 134 includes a patient-port body 142 having a first side 144 and a second, pouch-facing side 146. The patient-port body 142 also includes a first hollow attachment connector 148 sized and configured for mating with the at least one reduced pressure lumen 130 of the first multi-lumen conduit 124. The first hollow attachment connector 148 is fluidly coupled to a first fluid outlet 150 formed on the patient-port body 142. The patient-port interface 134 may be coupled to either the first 139 or second, animal-facing side 141 of the flexible pouch body 138.

The patient-port body 142 also includes a second hollow attachment connector 152 sized and configured for mating with the at least one sensing lumen 132 of the first multi-lumen conduit 124. The second hollow attachment connector 152 is fluidly coupled to a first pressure-sensing connector 154 on the second, pouch-facing side 146. The first pressure-sensing connector 154 is fluidly coupled to a first end of the first bypass conduit 140. The first pressure-sensing connector 154 may be substantially parallel to the surface of the second, pouch-facing side 146 and may include a conduit-channel 156. A first plurality of offsets 158 is formed on the second, pouch-facing side 146 of the patient-port body 142 for providing flow space 160. The flow space 160 assures space for reduced pressure to move fluids. In other words, the flow space 160 provides space for the fluids to expand and manifold into a fluid storage material 204 or other portion of the interior portion 136.

Referring now primarily to FIGS. 1-4, fluids are moved via pressure differential from the first fluid outlet 150 across the interior portion 136 of the inline storage pouch 106 to a second port 162 as suggested by arrows 163. The fluid is distributed throughout the interior portion 136 as the reduced pressure draws from the second port 162. The second port 162 fluidly couples the interior portion 136 to a second reduced-pressure lumen 164 of a second multi-lumen conduit 166. The second port 162 is shown coupled to the first side 139 of the flexible pouch body 138. The second port 162 may also be formed on the second, animal-facing side 141. Typically, the first port 133 and second port 162 are on opposite sides 139, 141 of the flexible pouch body 138.

The second reduced-pressure lumen 164 is fluidly coupled to the reduced-pressure source 112 of the therapy unit 110. The first bypass conduit 140 delivers fluid from the first port 133 to the second port 162. The first bypass conduit 140 is fluidly isolated from fluids in the interior portion 136 of the flexible pouch body 138. The second port 162 fluidly couples the first bypass conduit 140 to a second sensing lumen 168 of the second multi-lumen conduit 166. The second sensing lumen 168 may be fluidly coupled to a pressure sensing unit 170 of the therapy unit 110. The second port 162 may be any device that accomplishes at least two functions. First, the second port 162 fluidly couples the first bypass conduit 140 to the second sensing lumen 168. Second, the second port 162 fluid couples the second reduced-pressure lumen 164 to the interior portion 136 of the flexible pouch body 138. In one illustrative embodiment, the second port 162 is a device-port interface 172.

Referring now primarily to FIGS. 5-6, an illustrative embodiment of a device-port interface 172 is presented. The device-port interface 172 includes a device-port body 174 having a first side 176 and a second, pouch-facing side 178. The device-port body 174 includes a third hollow attachment connector 180 sized and configured for mating with the second reduced-pressure lumen 164. The third hollow attachment connector 180 is fluidly coupled to a fluid inlet 182. The third hollow attachment connector 180 is formed on (including coupled to) the device-port body 174.

The device-port body 174 also includes a fourth hollow attachment connector 184 sized and configured for mating with the second sensing lumen 168 of the second multi-lumen conduit 166. A second pressure-sensing connector 186 is fluidly coupled to the fourth hollow attachment connector 184. The second pressure-sensing connector 186 is fluidly coupled to a second end of the first bypass conduit 140. The second pressure-sensing connector 186 may be substantially parallel to the surface of the second, pouch-facing side 178 and may include a conduit-channel 187.

The device-port interface 172 may further include an offset 188 formed on the second, pouch-facing side 178 of the device-port body 174 for providing a filter space 192 for one or more hydrophobic filters with bacterial filtering properties. In this embodiment, the offset 188 is a wall 190 that forms the filter space 192. A filter 194 or multiple filters are disposed within the filter space 192. The filter 194 may be any material that prevents liquids from entering the fluid inlet 182. In one embodiment, the filter 194 includes a hydrophobic filter member, a manifolding material, and another hydrophobic filter member or any permutation thereof or functional device to prevent liquids from entering the fluid inlet 182. The filter 194 or filters are hydrophobic, bacterial filtering membranes that are located to prevent fluids and bacteria from progressing towards the therapy unit 110. As an illustrative, non-limiting embodiment, the filter membrane may be a GORE® MMT314 material available from W. L. Gore & Associates, Inc., Newark, Del. The one or more filters 194 are displaced from the base of the device-port interface 172 by castilated surface features (not explicitly shown) or other surface features designed to provide an open area of filter for flow. A charcoal filter may also be included to remove odor. In another illustrative embodiment, a porous polymer, gel-blocking filter may be included in the second reduced-pressure lumen 164.

Referring now primarily to FIGS. 1-2 and 7, the flexible pouch body 138 of the inline storage pouch 106 is formed with a first wall 196 and a second wall 198. The two walls 196, 198 are coupled or formed as a single unit to form the flexible pouch body 138. The flexible pouch body 138 has the interior portion 136 formed between the walls 196, 198. For example, in one illustrative embodiment, the first wall 196 and the second wall 198 are coupled by an attachment 200 at a peripheral edge 202 of the walls 196, 198. The attachment 200 may be formed using any known technique, including without limitation welding (e.g., ultrasonic or RF welding), bonding, adhesives, cements, stitching, staples, or another coupling device.

The first wall 196 and second wall 198 may be formed from any flexible, liquid-impermeable material. For example, the first wall 196 and second wall 198 may be formed from one or more of the following: natural rubbers, polyisoprene, styrene butadiene rubber, chloroprene rubber, polybutadiene, nitrile rubber, butyl rubber, ethylene propylene rubber, ethylene propylene diene monomer, chlorosulfonated polyethylene, polysulfide rubber, polyurethane (PU), EVA film, co-polyester, silicones, silicone drape, a 3M Tegaderm® drape, or a polyurethane (PU) drape such as one available from Avery Dennison Corporation of Pasadena, Calif., or other appropriate material. The inline storage pouch 106 may be sized to accommodate the quantity of liquid anticipated for a typical treatment time. In one illustrative, non-limiting embodiment, the interior portion 136 has a volume greater than 180 milliliters and less than 500 milliliters, but numerous sizes may be used.

The interior portion 136 formed by the flexible pouch body 138 may be filled at least in part by the fluid storage material 204. The storage material 204 may be formed from any material that receives fluids, including liquids; retains the fluids; and allows reduced pressure to be transmitted. In the illustrative embodiment of FIG. 7, the fluid storage material 204 comprises an absorbent member 206, a first wicking member 208, and a second wicking material 210. The absorbent member 206 may be any material that retains liquids and may comprise one or more of the following: Luquafleece® material, BASF 402c, Technical Absorbents 2317 available from Technical Absorbents (www.techabsorbents.com), sodium polyacrylate super absorbers, cellulosics (carboxy methyl cellulose and salts such as sodium CMC), or alginates. The first wicking member 208 and second wicking member 210 may be formed from one or more of the following: non-woven fabrics such as Libeltex TDL2 or other non-wovens from LIBELTEX bvba of Belgium (www.libeltex.com), woven fabrics including 3D spacer fabrics and Textiles (Baltex, Ilkeston, Derby, UK), open-cell foam, or sintered polymers. The wicking members 208, 210 may be formed by multiple layers of wicking materials that have been stacked or layered.

The first wicking member 208 and the second wicking member 210 may be disposed adjacent to one another at least at their peripheral edges 216 and coupled with an attachment 214 (analogous to attachment 200 as previously described). Thus, the wicking members 208, 210 surround the absorbent member 206. The peripheral edges 216 form overlapping portions and are held in contact with one another to provide a fluid coupling between the wicking members 208, 210. The wicking members 208, 210 may thus be in fluid communication with each other. The wicking members 208, 210 allow fluid flow between the wicking members 208, 210 and along the wicking members 208, 210 at times when the flow of fluid in the absorbent member 206 is inhibited or blocked. In this embodiment, the first bypass conduit 140 comprises a tube 218, but it could also be a web member 212 attached against a portion of wall 196 (FIG. 11), or any device that provides a path to move fluid through the interior portion 136 while remaining fluidly isolated from the interior portion 136.

Referring now primarily to FIGS. 2 and 8, another illustrative inline storage pouch 106 is presented. The inline storage pouch 106 is analogous in most respects to the inline storage pouch 106 of FIGS. 1, 2, and 7, and accordingly, some parts are labeled but not further described here. In this embodiment, the primary difference is that the flexible pouch body 138 is formed with one or more optional fluid-communication buttons 207.

Each fluid communication-button 207 may be formed by creating an aperture 209 in the absorbent member 206. The first wicking member 208 and second wicking member 210 are brought into contact in the aperture 209, and first wicking member 208 and second wicking member 210 are attached at or near the point of contact. The wicking members 208, 210 are attached using one or more attachments 211 (analogous to 214). This embodiment may be particularly useful in minimizing pressure drop across the inline storage pouch 106 when the wicking members 208, 210 are formed from a non-woven manifolding material. The fluid-communication buttons 207 enhance the degree of fluid communication between the first wicking member 208 and second wicking member 210.

Referring now primarily to FIGS. 2 and 9, another illustrative inline storage pouch 106 is presented. The inline storage pouch 106 is analogous in most respects to the inline storage pouch 106 of FIGS. 1, 2, and 7-8, and accordingly, some parts are labeled but not further described here. The primary difference in this embodiment is that a first plurality of offsets 215 has been formed and disposed between the first wall 196 and the fluid storage material 204. In this embodiment, the first plurality of offsets 215 may be positioned between the first wall 196 and the first wicking member 208. The first plurality of offsets 215 may include a first base 217.

The inline storage pouch 106 may also include a second plurality of offsets 219. The second plurality of offsets 219 may be disposed between the second wall 198 and the fluid storage material 204. In this embodiment, the second plurality of offsets 219 may be positioned between the second wicking member 210 and the second wall 198. The second plurality of offsets 219 may include a second base 221. The offsets 215, 219 create additional space for the flow of reduced pressure within the interior portion 136. The inline storage pouch 106 of FIG. 9 may be used with a high-vapor-transfer-rate material as described in connection with FIG. 14 below, but typically the first base 217 and second base 221 would be perforated.

The offsets 215, 219 may formed from any rigid or semi-rigid material approved for use in a body. The offsets 215, 219 are typically formed from a non-absorbent material. The offsets 215, 219 may be formed, for example, from a high-impact polystyrene and may be vacuumed formed to a desired shape (e.g., cylinder, tube, cone, or other shape) and sized as desired for the chamber or interior space. The offsets 215, 219 with their respective bases 217, 221 are flexible and reduced pressure can pass in between the offsets, i.e., through the bases 217, 221, which may permeable or perforated. The offsets 215, 219 facilitate open flow for reduced pressure transmission under compression. The offsets 215, 219 may vary in quantity and pattern or shape and size but should allow pressure to be transmitted and the inline storage pouch 106 to remain flexible. In one illustrative embodiment, the offsets 215, 219 may be any shape or size that provides clearance of at least 1 mm.

Referring now primarily to FIG. 10, another illustrative inline storage pouch 106 is presented. The inline storage pouch 106 is analogous in most respects to the inline storage pouch 106 of FIGS. 1, 2, and 7-9, and accordingly, some parts are labeled but not further described here. The primary difference in this embodiment is that the inline storage pouch 106 includes a first plurality of offsets 215 and a third wicking member 223. As in FIG. 9, the first plurality of offsets 215 are disposed between the first wall 196 and the fluid storage material 204 to create additional flow space for reduced pressure to flow. The third wicking member 223 may be disposed between the second wall 198 and the fluid storage material 204. The third wicking member 223 may be formed from the same materials as the first wicking member 208.

In this embodiment, the third wicking member 223 may be disposed between the second wall 198 and the second wicking member 210. The third wicking member 223 provides additional manifolding material for fluid flow. In other embodiments, additional wicking members may be added in addition to the third wicking member 223. Moreover, in other embodiments, one or more additional wicking members may be added between the first wall 196 and the absorbent member 206.

Referring now primarily to FIG. 11, another illustrative inline storage pouch 106 is shown in cross section. The inline storage pouch 106 is analogous in most respects to the inline storage pouch 106 of FIGS. 1, 2, and 7-10, and accordingly, some parts are labeled but not further described here. In this illustrative embodiment, a first bypass conduit 140 may be formed by the web member 212 attached against the portion of wall 196. The web member 212 may be formed from the same material as the first wall 196. The first bypass conduit 140 includes a conduit-manifold material 213. The conduit-manifold material 213 may be any material that is sufficient to prevent the first bypass conduit 140 from collapsing under reduced pressure.

Referring now primarily to FIG. 12, another illustrative inline storage pouch 106 is shown in cross section. The inline storage pouch 106 is analogous in most respects to the inline storage pouch 106 of FIGS. 1, 2, and 7-11, and accordingly, some parts are labeled but not further described here. In this illustrative embodiment, a first bypass conduit 140 is formed by using a third wall 199 that together with the first wall 196 forms the first bypass conduit 140. The third wall 199 may be formed from the same materials as the first wall 196. Like in FIG. 11, the first bypass conduit 140 may be at least partially filled with a conduit-manifold material 213. This embodiment allows the first bypass conduit 140 to extend the width of the flexible pouch body 138.

Referring now primarily to FIG. 13, another illustrative inline storage pouch 106 is shown in cross section. The inline storage pouch 106 is analogous in most respects to the inline storage pouch 106 of FIGS. 1, 2, and 7-12, and accordingly, some parts are labeled but not further described here. In FIG. 13, the fluid storage material 204 comprises an absorbent member 206 surrounded by a wicking member 208 that has been coated, extruded, or otherwise directly applied onto the exterior of the absorbent member 206.

Referring now primarily to FIG. 14, another illustrative inline storage pouch 106 is shown in cross section. The inline storage pouch 106 is analogous in most respects to the inline storage pouch 106 of FIGS. 1, 2, 7-13, and accordingly, some parts are labeled but not further described here. In FIG. 14, the first wall 196 or second wall 198 are formed from a high-vapor-transfer-rate material. The high-moisture-vapor-transfer-rate (“MVTR”) material may be formed from any material that allows vapor to egress but not liquids. “Moisture Vapor Transmission Rate” or “MVTR” represents the amount of moisture that can pass through a material in a given period of time. The high-moisture-vapor-transfer-rate material typically has a moisture vapor transmission rate greater than 300 g/m2/24 hours and more typically 1000 g/m2/24 hours or more. The high-moisture-vapor-transfer-rate material allows vapor to egress or diffuse from the interior portion 136, but not liquids.

The high-moisture-vapor-transfer-rate material may comprise one or more of the following: hydrophilic polyurethane, cellulosics, hydrophilic polyamides, an INSPIRE™ 2301 material from Exopack Advanced Coatings of Wrexham, United Kingdom; a thin, uncoated polymer drape; or polyvinyl alcohol, polyvinyl pyrrolidone, hydrophilic acrylics, hydrophilic silicone elastomers and copolymers of these. The INSPIRE™ 2301 illustrative film has an MVTR (inverted cup technique) of 14500-14600 g/m2/24 hours. See www.exopackadvancedcoatings.com. The high-moisture-vapor-transfer-rate materials may have various thicknesses, such as 10 to 40 microns (μm), e.g., 15, 20, 25, 30, 35, 40 microns (inclusive of all numbers in the stated range).

The inline storage pouch 106 has a flexible pouch body 138 with an interior portion 136. Like in FIG. 11, the interior portion 136 is at least partially filled with a storage material 204 that may be formed with a first wicking member 208, an absorbent member 206, and a second wicking member 210. The wicking members 208, 210 may be coupled at their peripheral edges 216 by an attachment 214 (analogous to attachment 200).

The inline storage pouch 106 of FIG. 14 is shown on the animal's epidermis 114. Some clearance between the epidermis 114 and inline storage pouch 106 may be provided by hair 220. Moisture from the animal's epidermis 114 may ingress into the interior portion 136 through the second wall 198, which is formed from a high-moisture-vapor-transfer-rate material. The ingress is due to a moisture imbalance. The moisture enters the second wicking member 210. In addition, moisture may egress the interior portion 136 through the first wall 196, which may also comprise a high-moisture-vapor-transfer-rate material. The egress is due to a moisture imbalance between the interior portion 136 and the external atmosphere across the high-moisture-vapor-transfer-rate material. In another embodiment, a third wicking member may be added on an exterior of the second wall 198 to wick moisture away from the animal's epidermis 114.

In operation according to one illustrative embodiment, the wound dressing 108 is applied to the tissue site 102. The inline storage pouch 106 is positioned at a desired location on the animal 104 or near the animal 104 depending on the application. If applied on the animal 104, the inline storage pouch 106 may be strapped, tapped, or otherwise secured to the animal 104. The inline storage pouch 106 is fluidly coupled to the wound dressing 108 to provide reduced pressure to the wound dressing 108 and to receive wound-site pressure from the tissue site 102. The therapy unit 110 may also be positioned on or near the animal 104. The therapy unit 110 is fluidly coupled to the inline storage pouch 106. The therapy unit 110 provides reduced pressure to the inline storage pouch 106 and receives the wound-site pressure for determining pressure at the tissue site 102. The therapy unit 110 may control the therapy, analyze any blockages, and provide alerts as described further below.

As operation continues, fluids are pulled from the animal 104 into the inline storage pouch 106. The fluid enters the first port 133 and is pulled toward the second port 162. As the fluid is pulled, the fluid is distributed throughout the interior portion 136 and particularly in the fluid storage material 204. As liquids build in the inline storage pouch 106, gases—typically air—continue to move or to manifold through the interior portion 136. The gases may move through the interior portion 136 primarily through the wicking members 208, 210 when included or through space created by the third wicking member 223 or by the offsets 215, 219. Once the inline storage pouch 106 at least partially fills, liquid reaches the second port 162 and the flow is discontinued. In another illustrative embodiment, baffles or internal walls may be added in the interior portion 136 to cause the fluid flow to take a tortuous path between the ports 133, 162.

Referring now primarily to FIGS. 15-17B, another illustrative inline storage pouch 106 is presented. The inline storage pouch 106 is analogous in most respects to the inline storage pouch 106 of FIGS. 1, 2, and 7-14, and accordingly, some parts are labeled but not further described here. In addition, components referenced but not explicitly shown are analogous to those previously presented. In this illustrative embodiment, the flexible pouch body 138 includes a first port 133 having a first reduced-pressure indicator 222 and a second port 162 having a second reduced-pressure indicator 224. The ports 133, 162 are shown on the same side of the flexible pouch body 138, but it should be understood that one or both of the ports 133, 162 may be located on the opposite side as shown in other figures herein.

The first reduced-pressure indicator 222 may be fluidly coupled to the interior portion 136 of the flexible pouch body 138 proximate to the first port 133 or as an aspect of the first port 133. The first reduced-pressure indicator 222 may be included as an aspect of the patient-port interface 134 as shown in FIG. 16. The first reduced-pressure indicator 222 provides a visual indication of whether or not the first reduced-pressure indicator 222 experiences a reduced pressure greater than a first threshold.

Similarly, the second reduced-pressure indicator 224 may be fluidly coupled to the interior portion 136 of the flexible pouch body 138 proximate to the second port 162 and may be part of the device-port interface 172. The second reduced-pressure indicator 224 provides a visual indication of whether or not the second port 162 experiences a reduced pressure greater than a second threshold, which may be the same as the first threshold.

Referring now primarily to FIGS. 16-17, the reduced-pressure indicators 222, 224 are described. The reduced-pressure indicators 222, 224 are analogous to one another. The reduced-pressure indicators 222, 224 may each be formed with a moving member 226 adapted to move when reduced pressure exceeds a threshold pressure (Pt). The reduced-pressure indicators 222, 224 have a visual indicator 228 associated with the moving member 226. In one embodiment, the visual indicator 228 is an indicator member 230 or portion, such as a disk-shaped member 232 (or button), or a member of any shape that signifies a changed state with respect to pressure.

The moving member 226 may be a collapsible wall 234 that has a first end 236 and a second end 238. The first end 236 may be coupled to the indicator member 230. The second end 238 may be coupled to a base 240. The collapsible wall 234 and indicator member 230 form a pressure vessel with base 240. The collapsible wall 234 may have a convex interior surface and may include baffles or other features to assist in collapsing at the threshold pressure.

When reduced pressure delivered to the interior portion 136 exceeds the threshold pressure (Pt), the collapsible wall 234 collapses (alone or with movement in the base 240) and causes the visual indicator 228 to go from a first position, e.g., an extended position, to a second position, e.g., a retracted position, as shown in FIGS. 17A and 17B, respectively. The collapsible walls 234 of the reduced-pressure indicator may be sized and shaped to collapse or move the indicator member 230 to be substantially flush or against the base 240 when the threshold reduced pressure (Pt) is achieved. When the pressure rises (with reference to absolute pressure) above the threshold reduced pressure (Pt), the collapsible wall 234 returns to the extended position. In other words, the reduced pressure causes the reduced-pressure indicator to collapse as long as there is adequate reduced pressure.

The thickness of the collapsible wall 234, wall material stiffness, and wall geometry are variables that impact the pressure at which the collapsible wall 234 collapses. The rigidity of the base 240 may also be a factor. While the wall thickness of the collapsible wall 234 may be determined using finite element analysis, it may be necessary to empirically determine the wall thickness to achieve movement at the threshold pressure (Pt). In some embodiments, the collapsible wall 234 may be designed so that the collapsible wall 234 collapses by sudden buckling as the threshold pressure (Pt) is crossed, providing a binary indication. The reduced-pressure indicator 222, 224 may be formed on the base 240 with other aspects of the patient-port interface 134 or device-port interface 172.

The reduced-pressure indicator 222, 224, interfaces 134, 172, and base 240 may be formed from a medical-grade, soft polymer or other pliable material, such as one or more of the following: polyurethane, polyethylene, polyvinyl chloride (PVC), fluorosilicone, ethylene-propylene, DEHP-free PVC, or other material. The components may be cast, or extruded, and may be formed as an integral unit.

In operation, if the pressure sensing unit 170 shows a lack of reduced pressure at the tissue site 102, the user may analyze the situation using the reduced-pressure indicators 222, 224. If pressure is being received at the first reduced-pressure indicator 222, i.e., the indicator member 230 shows that the collapsible wall 234 is still collapsed, then a problem exists between the tissue site 102 and the inline storage pouch 106. If the first reduced-pressure indicator 222 shows inadequate pressure, i.e., the indicator member 230 shows that the collapsible wall 234 is no longer collapsed and if the second reduced-pressure indicator 224 shows adequate pressure, i.e., the indicator member 230 shows that the collapsible wall 234 is still collapsed, then a problem exists within the inline storage pouch 106. If the second reduced-pressure indicator 224 shows inadequate pressure, i.e., the indicator member 230 shows that the collapsible wall 234 is no longer collapsed, then a problem exists with either the filter 194 being occluded or somewhere between the inline storage pouch 106 and the reduced-pressure source 112.

Referring now primarily to FIG. 18, another illustrative embodiment of an inline storage pouch 106 is presented. The inline storage pouch 106 is analogous in most respects to the inline storage pouch 106 of FIGS. 1, 2, and 7-14, and accordingly, some parts are labeled but not further described here. In addition, components referenced but not explicitly shown are analogous to those previously presented. The illustrative embodiment of FIG. 18 includes a second bypass conduit 242 fluidly disposed within and fluidly isolated from the interior portion 136 of the flexible pouch body 138. The second bypass conduit 242 has a first end 244 and a second end 246. The first end 244 of the second bypass conduit 242 may be fluidly coupled to the interior portion 136 of the flexible pouch body 138 proximate to the first port 133 at a first pressure-sensing pad 248. In addition to the second reduced-pressure lumen 164 and second sensing lumen 168, the second multi-lumen conduit 166 also includes a first pouch-pressure-sensing conduit 250. The second end 246 of the second bypass conduit 242 may be fluidly coupled to the first pouch-pressure-sensing conduit 250. The first port 133 may be located on the second, animal-facing side of the flexible pouch body 138 and the second port 162 may be on the first side 139. In another illustrative embodiment, the ports 133, 162 may be on the same side or reverse sides as to what is described herein above

Still with reference to FIG. 18 and to a lesser extent to FIG. 2, the pressure sensing unit 170 may be fluidly coupled to the second sensing lumen 168 and separately to the first pouch-pressure-sensing conduit 250. Thus, therapy unit 110, which also may include a microprocessor 253, is able to determine the pressure at the tissue site 102 and also in the interior portion 136 of the flexible pouch body 138 proximate to the first port 133. The therapy unit 110 may check the pressure proximate the first port 133 (in the first pressure-sensing pad 248) proactively or if inadequate pressure, i.e., below a threshold, is determined at the tissue site 102. If adequate pressure exists in the first pressure-sensing pad 248 but not at the tissue site 102, the therapy unit 110 may provide an alert that a blockage exists between the inline storage pouch 106 and the tissue site 102. If inadequate pressure exists at the first pressure-sensing pad 248, the therapy unit 110 may signal that the inline storage pouch 106 is full or block exists between the inline storage pouch 106 and the reduced-pressure source 112.

Referring now primarily to FIG. 19 and to a lesser extent FIG. 2, another illustrative embodiment of an inline storage pouch 106 is presented. The inline storage pouch 106 is analogous in most respects to the inline storage pouch 106 of FIGS. 1, 2, 7-14, and 18, and accordingly, some parts are labeled but not further described here. In addition, components referenced but not explicitly shown are analogous to those previously presented.

In this embodiment, a second pressure-sensing pad 252 has been coupled proximate to the second port 162. The second pressure-sensing pad 252 includes a filter element (not explicitly shown) that becomes occluded when saturated with liquid. The second pressure-sensing pad 252 may be fluidly coupled to the interior portion 136 of the flexible pouch body 138 proximate to the second port 162. As before, the second multi-lumen conduit 166 further includes a first pouch-pressure-sensing conduit 250 fluidly coupled to the pressure sensing unit 170 of the therapy unit 110. When the therapy unit 110 detects that the second pressure-sensing pad 252 is occluded, the therapy unit 110 may signal that the inline storage pouch 106 is full.

Referring now primarily to FIG. 20 and to a lesser extent FIG. 2, another illustrative embodiment of an inline storage pouch 106 is presented. The inline storage pouch 106 is analogous in most respects to the inline storage pouch 106 of FIGS. 1, 2, 7-14, and 18-19 and accordingly, some parts are labeled but not further described here. In addition, components referenced but not explicitly shown are analogous to those previously presented.

In this embodiment, the inline storage pouch 106 includes the second bypass conduit 242 as in FIG. 18 fluidly coupled to the interior portion 136 of the flexible pouch body 138 proximate to the first port 133. The second bypass conduit 242 may also be fluidly coupled to the first pouch-pressure-sensing conduit 250. The inline storage pouch 106 also includes a second pressure-sensing pad 252 like in FIG. 19 fluidly coupled to the interior portion 136 of the flexible pouch body 138 proximate to the second port 162 and to a second pouch-pressure-sensing conduit 254. The second pouch-pressure-sensing conduit 254 may be fluidly coupled to the second pressure-sensing pad 252 and to a therapy unit 110.

The portion of the system 100 shown in FIG. 20 includes the therapy unit 110. The therapy unit 110 includes the reduced-pressure source 112 and pressure sensing unit 170. The pressure sensing unit 170 includes a first pressure sensing device 258, a second pressure sensing device 260, and a third pressure sensing device 262. The first pressure sensing device 258 is fluidly coupled to the pressure-assessment conduit 128 of the reduced-pressure interface 122 for determining a wound-site pressure, i.e., the pressure at the tissue site 102. The second pressure sensing device 260 may be fluidly coupled to the first pressure-sensing pad 248 for determining pressure proximate the first port 133. The third pressure sensing device 262 may be fluidly coupled to the second pressure-sensing pad 252 for determining pressure at the second port 162.

More particularly, the first pressure sensing device 258 may be fluidly coupled to the second sensing lumen 168 of the second multi-lumen conduit 166. The second sensing lumen 168 may also be fluidly coupled to the first bypass conduit 140 and to the sensing lumen 132 of the first multi-lumen conduit 124. The sensing lumen 132 may be fluidly coupled to the pressure-assessment conduit 128. The second pressure sensing device 260 may be fluidly coupled to the first pouch-pressure-sensing conduit 250. The first pouch-pressure-sensing conduit 250 may be fluidly coupled to the second bypass conduit 242. The second bypass conduit 242 may be fluidly coupled to first pressure-sensing pad 248 proximate to the first port 133. The third pressure sensing device 262 may be fluidly coupled to the second pouch-pressure-sensing conduit 254. The second pouch-pressure-sensing conduit 254 may be fluidly coupled to the second pressure-sensing pad 252.

With the portion of the system 100 shown in FIG. 20, the therapy unit 110 may pinpoint the location (or at least give an area) of blockage or may indicate that the inline storage pouch 106 is full. Referring now primarily to FIG. 21, one possible logic flow for operation of the system in FIG. 20 is presented. The process begins at step 264 and the first interrogatory box 266 inquires as to whether or not the desired pressure is being realized at the tissue site 102. The microprocessor 253 may determine this by comparing the pressure determined by the first pressure sensing device 258 with a selected pressure threshold. If the interrogatory is affirmative, the process continues back along path 268. If not, the microprocessor 253 may activate the reduced-pressure source 112 at step 270 to provide reduced pressure. Optionally a certain amount of time may be required before moving beyond step 270 and the interrogatory box 266 may be revisited.

With inadequate pressure existing, the interrogatory box 272 is reached and calls for the pressure to be checked at the second port 162 by the second pressure-sensing pad 252. The microprocessor 253 receives the pressure from the third pressure sensing device 262. If there is not a reduced pressure greater (i.e., more reduced with respect to absolute pressure) than a threshold reduced pressure at the second port 162, a flag is raised at step 274 that a blockage exists between the reduced-pressure source 112 and the inline storage pouch 106. If adequate pressure is at the second port 162, the problem must be elsewhere and the process continues to interrogatory box 276. Interrogatory box 276 inquires as to the pressure at the first port 133. The microprocessor 253 receives the pressure from the second pressure sensing device 260. If the pressure is inadequate, step 278 is reached an alert posted that the pouch is full or blocked.

If pressure exists at the first port 133 but not at the tissue site 102, which is the question of interrogatory box 280, an alert is issued at step 282 that a blockage exists between the inline storage pouch 106 and the wound dressing 108. If pressure exists at the tissue site 102, but is not adequate, another round of analysis may occur as suggested by path 284. A counter or chronograph may be included to limit the number of times through the cycle. Thus, after a maximum count or maximum time, an error flag may be provided. If adequate pressure is now realized at the tissue site 102, the answer to interrogatory box 286 is positive and the process continues from interrogatory box 286 to interrogatory box 266. This is one illustrative process and many others may be used. Those skilled in the art will understand various ways to implement the functionality in hardware or software. In addition, portions of this process may be used separately.

Referring now primarily to FIGS. 22-27, another illustrative embodiment of an inline storage pouch 300 is presented. The inline storage pouch 300 is analogous in many respects to the inline storage pouch 106 of the previous figures. The inline storage pouch 300 includes a pouch connector 302. The inline storage pouch 300 may be used as part of a system, e.g., system 100 of FIG. 1, to treat a tissue site on an animal.

The inline storage pouch 300 includes a flexible pouch body 304. The flexible pouch body 304 is formed with a first wall 306, a second wall 308, and a partitioning wall 310. The walls 306 and 308 form an interior portion partitioned by the partitioning wall 310 to form a first chamber 312 and a second chamber 314. The walls may be formed from any liquid-impermeable, flexible material, for example, polyurethane or any of those materials previously mentioned for the wall 196. The flexible pouch body 304 has a proximal end 316 and a distal end 318. A longitudinal axis extends generally between the proximal end 316 and the distal end 318.

A first manifolding material 320 is disposed within the first chamber 312. The first manifolding material 320 may be formed from the same materials as conduit-manifold material 213, e.g., BASF Luquafleece 402C or an analogous material.

A fluid storage material 321 is disposed within the second chamber 314. The fluid storage material 321 may be surrounded by a wicking material 322. The wicking material 322 may be one or more of the materials mentioned for wicking material 208, e.g., Libeltex TDL2 80 gsm or an analogous material. The wicking material 322 may be two separate pieces of material that are welded or otherwise coupled at their peripheral edges 324 to form a “tea bag” like arrangement containing the fluid storage material 321. The wicking material 322 may include one or more apertures, e.g., aperture 323 to facilitate a portion of the pouch connector 302 to extend therethrough.

A second manifolding material 326 may also be disposed within the second chamber 314. The second manifolding material 326 may be the same as first manifolding material 320, but in another embodiment is shown as a plastic layer 328 having offsets 330. The offsets 330 may be in the range 0.25-0.5 mils from a base of the plastic layer. The offsets 330 may be formed by injection molding the plastic layer 328 with offsets or vacuum forming. The offsets 330 may be ridges a shown, pegs, or any spacer. The second manifolding material 326 functions to ensure that the exudate collecting area (chamber) remains open. The offsets 330 may be the same or analogous to offsets 215, 219.

The pouch connector 302 is coupled to the flexible pouch body 304 proximate the proximal end 316 but could be placed at other locations. The pouch connector 302 receives fluids from the animal and delivers the fluids to the second chamber 314. The pouch connector 302 also fluidly couples reduced pressure received from a reduced-pressure source to the first chamber 312.

The pouch connector 302 includes a connector body 332 formed with an exudate chamber 334. The exudate chamber 334 has an intake port 336 for receiving the fluids from the animal and an outlet 338 for discharging the fluids from the animal. The intake port 336 may comprise a first tube connector 337 for coupling to a first conduit 339. The first tube connector 337 may include a tube lock 372. The first conduit 339 may be a multi-lumen conduit having a first reduced-pressure lumen 341 and a first pressure-sensing lumen 343. A displacement conduit 340 is fluidly coupled to the outlet port 338 and the second chamber 314 for delivering the fluids from the exudate chamber 334 to the second chamber 314. The displacement conduit 340 may be a tube or a hollow offset that is open or the like.

The connector body 332 is also formed with a reduced-pressure chamber 342. The exudate chamber 334 and reduced-pressure chamber 342 are fluidly isolated from each other within the pouch connector 302 by a portion of the connector body 332. The reduced-pressure chamber 342 has an intake port 344 for receiving fluids from the first chamber 312 and an outlet port 346 for discharging fluids. The outlet port 346 of the reduced-pressure chamber 342 is for receiving the reduced pressure from the reduced-pressure source. The outlet port 346 may comprise a tube connector 348 that couples to a second conduit 350 that is fluidly coupled to a reduced-pressure unit or source, e.g., therapy unit 110 in FIG. 2. The second conduit 350 may be a multi-lumen conduit that has a reduced-pressure lumen for delivering reduced pressure ultimately to the first chamber and a second pressure-sensing lumen for receiving reduced pressure ultimately from the first reduced-pressure sensing lumen via the pouch connector 302.

The connector body 332 may also includes a plurality of offsets 352 on the connector body 332 proximate to the intake port 344 of the reduced-pressure chamber 342. The offsets 352 may be in the range of 0.5 mils to several mils. The offsets 352 function to ensure fluid flow proximate to the intake port 344 in the first chamber 312.

The intake port 336 of the exudate chamber 334 may be substantially parallel to the outlet port 346 of the reduced-pressure chamber 342. The flexible pouch body 304 has a longitudinal axis (substantially parallel to section line 23-23 in FIG. 22) that may be substantially parallel to the axis of the intake port 336 of the exudate chamber 334 and may be perpendicular to the axis of the displacement conduit 340.

The partitioning wall 310 of the flexible pouch body 304 is formed with an exudate aperture 354 for receiving a portion of the pouch connector 302, e.g., the displacement conduit 340, into the second chamber 314. The partitioning wall 310 may be coupled to the displacement conduit 340 to form a fluid seal to prevent fluid from entering the first chamber 312 from the second chamber at that point. The coupling may be formed using any coupling technique, e.g., glue, epoxy, UV glue, welds, bonds, or other techniques.

A first connector aperture 355 may be formed in the first manifold material 320 on the proximal end 316. The exudate aperture 354 is formed on the proximal end of the partitioning wall 310 and is sized and configured to align with exudate aperture 354. At the other end, the distal end of the partitioning wall 310, a return aperture 356 is formed for allowing fluid flow from the second chamber 314 into the first chamber 312. Stated another way, reduced pressure may flow from the first chamber 312 through the return aperture 356 to the second chamber 314. A primary filter 358, e.g., a hydrophobic filter, covers the return aperture 356 to inhibit liquids from entering the first chamber 312. A secondary filter 360 may also be included that covers the fluid path of the return aperture 356. A piece of manifolding material 362 may be used to separate the primary filter 358 and the secondary filter 360. An apron of polyurethane 364 or other material may be used to secure secondary filter 360 and the manifolding material 362 to a first side of the partitioning wall 310. A charcoal filter or other odor filter may be added as well.

A second connector aperture 366 may be formed in the first wall 306 to allow a portion of the pouch connector 302 to extend through the second connector aperture 366. The second connector aperture 366 may facilitate coupling a portion of the first wall 306 to a base portion 368 of the pouch connector 302.

As shown best in FIG. 24, the fluid storage material 321 may have one or more apertures 370. The apertures 370 facilitate coupling of a portion of the partitioning wall 310 to the second wall 314 at locations between the proximal and distal ends. While not explicitly shown, apertures in the wicking material 322 may be formed that align with the apertures 370.

Referring primarily to FIGS. 22 and 26, the pressure-sensing lumen 343 of first conduit 339 is fluidly coupled to a pressure-sensing channel 345 at a first end 347. The pressure-sensing channel 345 is formed in the connector body 332 of the pouch connector 302. The pressure-sensing channel 345 allows a fluid to be communicated through the pouch connector 302. A second end 349 of the pressure-sensing channel 345 is fluidly coupled to a pressure-sensing lumen (not explicitly shown) in the second conduit 350 that is fluidly coupled to a reduced-pressure unit, e.g., therapy unit 110 in FIG. 2, that thereby monitors the pressure at the tissue site on the animal.

Although certain illustrative, non-limiting embodiments have been presented, it should be understood that various changes, substitutions, permutations, and alterations can be made without departing from the scope the appended claims. It will be appreciated that any feature that is described in connection to any one embodiment may also be applicable to any other embodiment. For example, the bypass conduit shown in one embodiment, e.g., 140 in FIG. 7, may be used in FIG. 11 or vice versa.

It will be understood that the benefits and advantages described above may relate to one embodiment or may relate to several embodiments. It will further be understood that reference to “an” item refers to one or more of those items.

The steps of the methods described herein may be carried out in any suitable order, or simultaneously where appropriate.

Where appropriate, features of any of the embodiments described above may be combined with features of any of the other embodiments described to form further examples having comparable or different properties and addressing the same or different problems.

It will be understood that the above description of preferred embodiments is given by way of example only and that various modifications may be made by those skilled in the art. The above specification, examples and data provide a complete description of the structure and use of exemplary embodiments of the invention. Although various embodiments of the invention have been described above with a certain degree of particularity, or with reference to one or more individual embodiments, those skilled in the art could make numerous alterations to the disclosed embodiments without departing from the scope of the claims.

Locke, Christopher Brian, Pratt, Benjamin Andrew, Rider, Elliott James

Patent Priority Assignee Title
10968543, Dec 01 2011 CONVATEC TECHNOLOGIES INC Wound dressing for use in vacuum therapy
11116884, Dec 08 2010 CONVATEC TECHNOLOGIES INC. Integrated system for assessing wound exudates
11135315, Nov 30 2010 CONVATEC TECHNOLOGIES INC. Composition for detecting biofilms on viable tissues
11241339, Nov 29 2011 Convatec Inc. Perforated binder for laminated wound dressing
11241525, Dec 08 2010 CONVATEC TECHNOLOGIES INC. Wound exudate monitor accessory
11266774, Jul 08 2016 CONVATEC TECHNOLOGIES INC. Fluid collection apparatus
11286601, Dec 20 2012 Convatec Technologies, Inc. Processing of chemically modified cellulosic fibres
11331221, Dec 27 2019 Convatec Limited Negative pressure wound dressing
11452808, Jul 08 2016 Fluid flow sensing
11458044, Sep 29 2008 CONVATEC TECHNOLOGIES INC Wound dressing
11583430, Sep 02 2011 CONVATEC LTD. Skin contact material
11596554, Jul 08 2016 CONVATEC TECHNOLOGIES INC. Flexible negative pressure system
11628093, May 08 2008 CONVATEC TECHNOLOGIES INC Wound dressing
11723808, Mar 30 2016 CONVATEC TECHNOLOGIES INC.; Synovo GmbH; QUALIZYME DIAGNOSTICS GMBH AND CO KG Detecting microbial infections in wounds
11740241, Mar 30 2016 Synovo GmbH Construct including an anchor, an enzyme recognition site and an indicator region for detecting microbial infection in wounds
11771819, Dec 27 2019 Convatec Limited Low profile filter devices suitable for use in negative pressure wound therapy systems
Patent Priority Assignee Title
1355846,
2547758,
2632443,
2682873,
2910763,
2969057,
3066672,
3367332,
3520300,
3568675,
3648692,
3682180,
3826254,
4080970, Nov 17 1976 Post-operative combination dressing and internal drain tube with external shield and tube connector
4096853, Jun 21 1975 Hoechst Aktiengesellschaft Device for the introduction of contrast medium into an anus praeter
4139004, Feb 17 1977 Bandage apparatus for treating burns
4165748, Nov 07 1977 Catheter tube holder
4184510, Mar 15 1977 Fibra-Sonics, Inc. Valued device for controlling vacuum in surgery
4233969, Nov 11 1976 ANSONIA NOMINEES LIMITED, 1 LOVE LANE, LONDON, EC2; ENGLISH ASSOCIATION OF AMERICAN THE, BOND AND SHARE HOLDERS LIMITED, 4 FORE STREET, LONDON EC2; FOSTER AND BRAITHWAITE, 22 AUSTIN FRIARS, LONDON, EC2; JESSEL GROUP THE, 30 REIGATE HILL, REIGATE, SURREY RH2 OAR; STRABUL NOMINEES LIMITED, 3 MOORGATE PLACE, LONDON, EC2; LLOYDS BANK BRANCHES NOMINEES LIMITED, 111 OLD BROAD STREET, LONDON, EC2 Wound dressing materials
4245630, Oct 08 1976 T. J. Smith & Nephew, Ltd. Tearable composite strip of materials
4256109, Jul 10 1978 Allegiance Corporation Shut off valve for medical suction apparatus
4261363, Nov 09 1979 C R BARD, INC , A CORP OF NJ Retention clips for body fluid drains
4275721, Nov 28 1978 Procter & Gamble Hygien Aktiebolag Vein catheter bandage
4284079, Jun 28 1979 Method for applying a male incontinence device
4297995, Jun 03 1980 KEY PHARMACEUTICALS, INC Bandage containing attachment post
4333468, Aug 18 1980 Mesentery tube holder apparatus
4373519, Jun 26 1981 Minnesota Mining and Manufacturing Company Composite wound dressing
4382441, Dec 06 1978 Device for treating tissues, for example skin
4392853, Mar 16 1981 Sterile assembly for protecting and fastening an indwelling device
4392858, Jul 16 1981 Sherwood Services AG; TYCO GROUP S A R L Wound drainage device
4419097, Jul 31 1981 Rexar Industries, Inc. Attachment for catheter tube
4465485,
4475909, May 06 1982 Male urinary device and method for applying the device
4480638, Mar 11 1980 Cushion for holding an element of grafted skin
4525166, Nov 21 1981 B BRAUN-SSC AG Rolled flexible medical suction drainage device
4525374, Feb 27 1984 MANRESA, INC Treating hydrophobic filters to render them hydrophilic
4540412, Jul 14 1983 The Kendall Company Device for moist heat therapy
4543100, Nov 01 1983 Catheter and drain tube retainer
4548202, Jun 20 1983 Ethicon, Inc. Mesh tissue fasteners
4551139, Feb 08 1982 Marion Laboratories, Inc. Method and apparatus for burn wound treatment
4569348, Feb 22 1980 VELCRO INDUSTRIES B V Catheter tube holder strap
4605399, Dec 04 1984 Complex, Inc. Transdermal infusion device
4608041, Oct 14 1981 Device for treatment of wounds in body tissue of patients by exposure to jets of gas
4640688, Aug 23 1985 Mentor Corporation Urine collection catheter
4655754, Nov 09 1984 Stryker Corporation Vacuum wound drainage system and lipids baffle therefor
4664662, Aug 02 1984 Smith and Nephew Associated Companies plc Wound dressing
4710165, Sep 16 1985 SURGIDYNE, INC Wearable, variable rate suction/collection device
4733659, Jan 17 1986 Seton Company Foam bandage
4743232, Oct 06 1986 The Clinipad Corporation Package assembly for plastic film bandage
4758220, Sep 26 1985 ALCON MANUFACTURING, LTD Surgical cassette proximity sensing and latching apparatus
4787888, Jun 01 1987 University of Connecticut Disposable piezoelectric polymer bandage for percutaneous delivery of drugs and method for such percutaneous delivery (a)
4826494, Nov 09 1984 Stryker Corporation Vacuum wound drainage system
4838883, Mar 07 1986 Nissho Corporation Urine-collecting device
4840187, Sep 11 1986 BARD LIMITED, PENNYWELL INDUSTRIAL ESTATE, SUNDERLAND SR4 9EW, ENGLAND Sheath applicator
4863449, Jul 06 1987 Hollister Incorporated Adhesive-lined elastic condom cathether
4872450, Aug 17 1984 Wound dressing and method of forming same
4878901, Dec 07 1987 Condom catheter, a urethral catheter for the prevention of ascending infections
4897081, May 25 1984 TMCA FOUNDATION INC Percutaneous access device
4906233, May 29 1986 Terumo Kabushiki Kaisha Method of securing a catheter body to a human skin surface
4906240, Feb 01 1988 Innovative Technologies Limited Adhesive-faced porous absorbent sheet and method of making same
4919654, Aug 03 1988 KALT MEDICAL CORPORATION, A CORP OF FLORIDA IV clamp with membrane
4941882, Mar 14 1987 Smith and Nephew Associated Companies, p.l.c. Adhesive dressing for retaining a cannula on the skin
4953565, Nov 26 1986 Shunro Tachibana Endermic application kits for external medicines
4969880, Apr 03 1989 KCI Licensing, Inc Wound dressing and treatment method
4985019, Mar 11 1988 Warsaw Orthopedic, Inc X-ray marker
5037397, Dec 27 1985 Medical Distributors, Inc. Universal clamp
5086170, Jan 16 1989 Roussel Uclaf Process for the preparation of azabicyclo compounds
5092858, Mar 20 1990 Becton, Dickinson and Company Liquid gelling agent distributor device
5100396, Apr 03 1989 KCI Licensing, Inc Fluidic connection system and method
5134994, Feb 12 1990 SAY, SAMUEL L AND BETTY JANE SAY, TRUSTEES OF THE SAY FAMILY TRUST DATED DECEMBER 2, 1995 Field aspirator in a soft pack with externally mounted container
5149331, May 03 1991 Ariel, Ferdman Method and device for wound closure
5167613, Mar 23 1992 The Kendall Company Composite vented wound dressing
5176663, Dec 02 1987 Principal AB; PHARMARK INNOVATIONS, LTD ; INNOVATIVE THERAPIES, INC Dressing having pad with compressibility limiting elements
5215522, Jul 23 1984 CITIBANK, N A Single use medical aspirating device and method
5232453, Jul 14 1989 CONVATEC TECHNOLOGIES INC Catheter holder
5261893, Apr 03 1989 KCI Licensing, Inc Fastening system and method
5278100, Nov 08 1991 Micron Technology, Inc. Chemical vapor deposition technique for depositing titanium silicide on semiconductor wafers
5279550, Dec 19 1991 Gish Biomedical, Inc. Orthopedic autotransfusion system
5298015, Jul 11 1989 Nippon Zeon Co., Ltd. Wound dressing having a porous structure
5342376, May 03 1993 Ethicon, Inc Inserting device for a barbed tissue connector
5344415, Jun 15 1993 DeRoyal Industries, Inc. Sterile system for dressing vascular access site
5358494, Jul 11 1989 Principal AB; PHARMARK INNOVATIONS, LTD Irrigation dressing
5437622, Apr 29 1992 Laboratoire Hydrex (SA) Transparent adhesive dressing with reinforced starter cuts
5437651, Sep 01 1993 Edwards Lifesciences Corporation Medical suction apparatus
5527293, May 14 1901 KCI Licensing, Inc Fastening system and method
5549584, Feb 14 1994 Smith & Nephew, Inc Apparatus for removing fluid from a wound
5556375, Jun 16 1994 Hercules Incorporated Wound dressing having a fenestrated base layer
5607388, Jun 16 1994 Hercules Incorporated Multi-purpose wound dressing
5636643, Nov 14 1991 WAKE FOREST UNIVERSITY HEALTH SCIENCES Wound treatment employing reduced pressure
5645081, Nov 14 1991 WAKE FOREST UNIVERSITY HEALTH SCIENCES Method of treating tissue damage and apparatus for same
6071267, Feb 06 1998 KCI Licensing, Inc Medical patient fluid management interface system and method
6135116, Jul 28 1997 KCI Licensing, Inc Therapeutic method for treating ulcers
6241747, May 03 1993 Ethicon, Inc Barbed Bodily tissue connector
6287316, Mar 26 1999 Ethicon, Inc Knitted surgical mesh
6345623, Sep 12 1997 KCI Licensing, Inc Surgical drape and suction head for wound treatment
6488643, Oct 08 1998 Huntleigh Technology Limited Wound healing foot wrap
6493568, Jul 19 1994 Huntleigh Technology Limited Patient interface system
6553998, Sep 12 1997 KCI Licensing, Inc Surgical drape and suction head for wound treatment
6814079, Sep 12 1997 KCI Licensing, Inc Surgical drape and suction head for wound treatment
7846141, Sep 03 2002 Smith & Nephew, Inc Reduced pressure treatment system
8062273, Sep 03 2002 Smith & Nephew, Inc Reduced pressure treatment system
8172817, Jan 31 2007 Allegiance Corporation Liquid collection system and related methods
8216198, Jan 09 2009 Smith & Nephew, Inc Canister for receiving wound exudate in a negative pressure therapy system
8251979, May 11 2009 Smith & Nephew, Inc Orientation independent canister for a negative pressure wound therapy device
8257327, Oct 28 2003 Smith & Nephew PLC Wound cleansing apparatus with actives
8398614, Oct 28 2002 Smith & Nephew PLC Apparatus for aspirating, irrigating and cleansing wounds
8449509, Apr 05 2004 Smith & Nephew, Inc Flexible reduced pressure treatment appliance
8529548, Apr 27 2004 Smith & Nephew PLC Wound treatment apparatus and method
8535296, Oct 28 2002 Smith & Nephew PLC Apparatus for aspirating, irrigating and cleansing wounds
8551060, Jul 17 2008 Smith & Nephew, Inc Subatmospheric pressure mechanism for wound therapy system and related methods therefor
8568386, May 11 2009 Smith & Nephew, Inc Orientation independent canister for a negative pressure wound therapy device
8679081, Jan 09 2009 Smith & Nephew, Inc Canister for receiving wound exudate in a negative pressure therapy system
8834451, Oct 28 2002 Smith & Nephew PLC In-situ wound cleansing apparatus
8926592, Oct 28 2003 Smith & Nephew PLC Wound cleansing apparatus with heat
9017302, Jul 21 2008 Smith & Nephew, Inc Thin film wound dressing
9198801, Apr 05 2004 Smith & Nephew, Inc Flexible reduced pressure treatment appliance
9211365, Sep 03 2002 Smith & Nephew, Inc Reduced pressure treatment system
9289542, Oct 28 2003 Smith & Nephew PLC Wound cleansing apparatus
20020077661,
20020115951,
20020120185,
20020143286,
20070084866,
20140163491,
20140276492,
20150080788,
AU550575,
AU745271,
AU755496,
CA2005436,
DE2640413,
DE29504378,
DE4306478,
EP100148,
EP117632,
EP161865,
EP358302,
EP1018967,
GB2195255,
GB2197789,
GB2220357,
GB2235877,
GB2329127,
GB2333965,
GB692578,
JP4129536,
SG71559,
WO8002182,
WO8704626,
WO90010424,
WO93009727,
WO94020041,
WO9605873,
WO9718007,
WO9913793,
/////////////
Executed onAssignorAssigneeConveyanceFrameReelDoc
Jan 31 2012PRATT, BENJAMIN A KCI Licensing, IncASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0392620825 pdf
Jan 31 2012RIDER, ELLIOTTKCI Licensing, IncASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0392620825 pdf
Jan 31 2012LOCKE, CHRISTOPHER BRIANKCI Licensing, IncASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0392620825 pdf
Jul 26 2016KCI Licensing, Inc.(assignment on the face of the patent)
Sep 20 2016KCI Licensing, IncWILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENTSECOND LIEN SECURITY AGREEMENT0400980268 pdf
Sep 20 2016LifeCell CorporationWILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENTSECOND LIEN SECURITY AGREEMENT0400980268 pdf
Sep 20 2016KCI USA, INC WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENTSECOND LIEN SECURITY AGREEMENT0400980268 pdf
Oct 06 2016KCI USA, INC WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENTLIMITED THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0402910237 pdf
Oct 06 2016LifeCell CorporationWILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENTLIMITED THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0402910237 pdf
Oct 06 2016KCI Licensing, IncWILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENTLIMITED THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0402910237 pdf
Feb 03 2017WILMINGTON TRUSTKCI USA, INC RELEASE OF SECURITY INTEREST REEL FRAME 040098 02680416660320 pdf
Oct 11 2019WILMINGTON TRUST, NATIONAL ASSOCIATIONKCI USA, INC RELEASE OF SECURITY INTEREST IN PATENTS0509660547 pdf
Oct 11 2019WILMINGTON TRUST, NATIONAL ASSOCIATIONKCI Licensing, IncRELEASE OF SECURITY INTEREST IN PATENTS0509660547 pdf
Date Maintenance Fee Events
Sep 04 2023REM: Maintenance Fee Reminder Mailed.
Feb 19 2024EXP: Patent Expired for Failure to Pay Maintenance Fees.


Date Maintenance Schedule
Jan 14 20234 years fee payment window open
Jul 14 20236 months grace period start (w surcharge)
Jan 14 2024patent expiry (for year 4)
Jan 14 20262 years to revive unintentionally abandoned end. (for year 4)
Jan 14 20278 years fee payment window open
Jul 14 20276 months grace period start (w surcharge)
Jan 14 2028patent expiry (for year 8)
Jan 14 20302 years to revive unintentionally abandoned end. (for year 8)
Jan 14 203112 years fee payment window open
Jul 14 20316 months grace period start (w surcharge)
Jan 14 2032patent expiry (for year 12)
Jan 14 20342 years to revive unintentionally abandoned end. (for year 12)